About Biosceptre international

About company

Biosceptre has identified a cancer target, nf-P2X7, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs directed to this target have the potential to treat all of these cancers. The Company is conducting multiple clinical trials to generate data that will underpin the potential of the technology. Concurrently Biosceptre is developing diagnostics that can detect and monitor cancer.